Key result
Stress management trials for chronic heart failure enroll ~39% women, with higher rates linked to hypertension.
Why the study?
Stress management interventions can alleviate psychosocial stress in women with heart failure, but their participation rates and predictors of participation in these trials were not summarized.
What are the participation rates and predictors of participation for women in stress management interventions for chronic heart failure?
Meta-Analysis (n=3,649)
What are the participation rates and predictors of participation for women in stress management interventions for chronic heart failure?
Women comprise only 38.8% of participants in stress management intervention trials for chronic heart failure, highlighting a need for improved inclusion.
Answers are grounded in this paper and cite their sources.
Women remain underrepresented in stress management trials for chronic heart failure; this challenges generalizability and extends calls for inclusive enrollment.
Stress management interventions (SMIs) can alleviate the psychosocial stress often experienced by women with heart failure. The purpose of this meta-analysis was to summarize women’s participation rates, and predictors of participation, in SMIs for the management of psychosocial distress in women with chronic HF. Studies were retrieved from bibliographic databases, reference sections of relevant papers, and research registries. Included studies (a) evaluated a SMI approach for the management of chronic HF, (b) sampled chronic HF patients, and (c) used a randomized controlled trial (RCT) design. Independent coders extracted the relevant data. Thirty-five RCTs met inclusion criteria (N = 3,649; mean age = 63.5 ± 7.0 years). All studies sampled both men and women; the mean proportion of women who participated in the trials was 38.8% (95% confidence interval [CI] = 34.5–43.4; I2 = 82.4, 95% CI = 81.0–83.6). Women’s participation rates were higher in studies sampling more HF patients with hypertension (B = 1.01, SE = 0.45, P = .046) but fewer HF patients prescribed beta blockers (B = −1.10, SE = 0.33, P = .006), F (2,12) = 6.27, P = 0.014, adjusted R2 = 61%. SMIs may offer women a complementary or integrative approach to standard treatment to help manage the psychological distress associated with HF. Future research should explore the potential benefits of offering stress management approaches to women as part of comprehensive HF care.
No takes yet. Share an insight, caveat, or question.
Scott‐Sheldon et al. (2021) conducted a meta-analysis in chronic heart failure (n=3,649). Stress management interventions was evaluated on Women's participation rates (95% CI 34.5-43.4). Stress management interventions for chronic heart failure had a mean female participation rate of 38.8%, which was higher in studies with more hypertension and fewer beta-blockers.
Synapse has enriched 10 related papers. Consider them for comparative context: